Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kenna D. Payne"'
Publikováno v:
Journal of Substance Use. 23:36-42
It is important to assess which dispensed medications remain unused as accumulated home medications serve as a source for poisonings, abuse, and misuse. The objective of this study was to characterize and quantify controlled substances relinquished a
Publikováno v:
Expert review of clinical pharmacology. 11(2)
Methicillin-resistant Staphylococcus aureus (MRSA) is a problematic pathogen in both outpatient and inpatient settings. Research to optimize the dosing of these agents is needed to slow the development of antimicrobial resistance and to decrease the
Autor:
Shibin Varghese, Ronald G. Hall nd, Lincy Varughese, Michael Thatcher, Michelle Ndiulor, Wei Wei, Kenna D. Payne
Publikováno v:
Expert review of clinical pharmacology. 10(5)
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a predominant pathogen resulting in significant morbidity and mortality. Optimal dosing of anti-MRSA agents is needed to help prevent the development of antimicrobial re
Autor:
Kenna D. Payne, Ronald G. Hall
Publikováno v:
Expert review of anti-infective therapy. 14(2)
Obesity is a worldwide epidemic associated with multiple comorbidities that increase the risk of hospitalization. Very little pharmacokinetic data are available for antifungal agents in obesity, as this population is often excluded from drug developm
Autor:
Amy M. Bain, Roger Bedimo, Anita P. Rahman, Stephen L. Vu, Susan A. Eaton, Ronald G. Hall, Sean T. Nguyen, Anthony J. Busti, Kenna D. Payne
Publikováno v:
The American Journal of Medicine. 121:515-518
There is a paucity of data available regarding the dosing of antimicrobials in obesity. However, data are available demonstrating that vancomycin should be dosed on the basis of actual body weight.This study was conducted at 2 tertiary care medical c
Autor:
Roger Bedimo, Anita P. Rahman, Maria C. Rodriguez-Barradas, Amy M. Bain, Kenna D. Payne, Anthony J. Busti, Darego O. Maclayton
Publikováno v:
American Journal of Infectious Diseases. 4:147-151
The objective of present research is to evaluate the lipid lowering efficacy and safety of switching within non-nucleoside reverse transcriptase inhibitors (NNRTI) in HIV-infected patients. This is a multicenter, retrospective study utilizing a compr
Autor:
Amy M. Baia, Anita P. Rahman, Sean T. Nguyen, Susan A. Eaton, Kenna D. Payne, Anthony J. Busti
Publikováno v:
American Journal of Infectious Diseases. 4:124-130
Pravastatin has generally been considered a safe and effective option for HIV-infected patients on highly active antiretroviral therapy (HAART). However, pravastatin concentrations are known to significantly decrease with concomitant efavirenz (EFV)
Autor:
Ronald G. Hall, Kenna D. Payne
Publikováno v:
Expert review of anti-infective therapy. 12(7)
Obesity is a global pandemic affecting 33% of adults in the United States. Obese persons receiving cefazolin or fluconazole have been shown to have worse outcomes with suboptimal dosing. Studies evaluating the safety of colistin, daptomycin, and vanc
Autor:
Amy M. Bain, Roger Bedimo, Anthony J. Busti, Kenna D. Payne, Susan A. Eaton, Anita P. Rahman, Sean T. Nguyen
Publikováno v:
Pharmacotherapy. 28(7)
Study Objectives. To evaluate the safety and efficacy of simvastatin for treatment of dyslipidemia in patients with the human immunodeficiency virus (HIV) who were receiving efavirenz-based highly active antiretroviral therapy (HAART), and to evaluat
Autor:
Jon D. Herrington, Anthony J. Busti, Anita P. Rahman, Roger Bedimo, Kenna D. Payne, Amy M. Bain, Darego O. Maclayton, Susan A. Eaton, Maria C. Rodriguez-Barradas, Sean T. Nguyen
Publikováno v:
Pharmacotherapy. 28(3)
To evaluate the efficacy, safety, and lipid-lowering effects after switching from a non-atazanavir-containing, protease inhibitor-based highly active antiretroviral therapy (HAART) to atazanavir-ritonavir-based HAART in patients infected with human i